Lukemia Flashcards
Myelogenous Leukemia
Leukemia characterized by proliferation of myeloid tissue (as of the bone marrow and spleen) and an abnormal increase in the number of granulocytes, myelocytes, and myeloblasts in the circulating blood
Development of Leukemia in the Bloodstream
Stage 1- Normal Stage 2- Symptoms Stage 3- Diagnosis Stage 4- Worsening Stage 5a- Anemia Stage 5b- Infection
Acute myeloid leukemia (AML) Etiology
Genetic damage to the DNA of a single cell in the bone marrow that primarily affects older people.
Acute myeloid leukemia (AML)
cancer of the blood-forming tissue (bone marrow).
causes bone marrow to produce too many immature white blood cells (blast cells).
Suppresses normal blood cell production.
…leads to Anemia, leukopenia, thrombocytopenia
Acute Myeloid Leukemia (AML) Physical Findings
Fever (unexplained for >3 weeks) Multiple bruises Unexplained infections Bleeding/bruising/petechiae (gingivae, GI bleed) Splenomegaly Sternal tenderness
Treatments for AML
Chemotherapy Phase One – Induction therapy Phase Two – Intensification therapy Phase Three – Maintenance Radiation therapy for certain cases Bone marrow transplantation
Acute Lymphoid Leukemia (ALL) Incidence
Mostly affects children, accounts for 3/4 of childhood leukemia (peak age 4 years)
Comprises less than 30% of leukemia in young adults
May be B-cell, T-cell, or null-type (non-B, non-T cell)
Acute Myeloid Leukemia (AML) Presenting Symptoms
Fatigue Shortness of breath on exertion Easy bruising Bleeding in the nose or from the gums Prolonged bleeding from minor cuts Recurrent minor infections or poor healing of minor cuts Loss of appetite or weight loss Mild fever
Symptoms usually present for 3 or more months before diagnosis is made
ALL Common Sx with children:
Fever Bleeding Easy bruising Petechiae Bone pain Fatigue Shortness of breath Weight loss / failure to thrive
Acute Lymphoid Leukemia (ALL)
Clonal proliferation and accumulation of blast cells in blood, bone marrow and other organs
Disorder originates in single B or T lymphocyte progenitor
Heterogenous disease with different biological subtypes
Incidence in adults : 20% of acute leukemias
Etiology - unknown
Acute Lymphoid Leukemia (ALL) Hematological Findings
Anemia (normochromic, normocytic)
WBC < 5,000 (or > 25,000)
Leukocytosis (median = 15,000)
Thrombocytopenia
Smear, Blast cells (< 50,000)
Immunologic classification of ALL
B- lineage (85%) Markers:
Typically is CD10+, CD19+, and sometimes CD20+
T-lineage (15%):
Positive for CDs 2, 3, 4, 5, 7, and 8.
Chronic Myeloid Leukemia (CML)
Proliferative disorder of hematopoietic stem cells
Well-characterized clinical course
Philadelphia (Ph) chromosome (Unique chromosomal abnormality)
Bcr-Abl tyrosine kinase: A single molecular abnormality that causes transformation of a hematopoietic progenitor into a malignant clone
Chronic Myeloid Leukemia (CML) Incidence
1-2 cases per 100,000 people/year
Higher among men than women
Median age of presentation is 50 yo
Chronic Myeloid Leukemia (CML) Clinical Features
40% asymptomatic Chronic phase Splenomegaly often massive (Increasing abdominal girth) Features of anaemia Abnormal platelet function (Bruising, epistaxis, menorrhagia) Hyperleukocytosis Chronic infection Fever